What Should Parents Ask an Osteosarcoma Specialist?

When your child is diagnosed with osteosarcoma, assembling the right care team is an essential first step. Because pediatric osteosarcoma is a rare and complex disease, consensus guidelines recommend that treatment and diagnosis be coordinated with a specialized sarcoma center ^[1]. The goal is to find a center with deep experience, a coordinated multidisciplinary team, and the infrastructure to support your child safely through intense treatments ^[2][3].

Below is an evidence-based checklist of specific questions to ask when interviewing a pediatric sarcoma care team. Remember that it is entirely appropriate to seek a second opinion, and many families travel for initial planning while sharing some routine care with local hospitals.

1. Surgical Experience and Options

While the medical literature does not define a strict “minimum number” of annual cases for a hospital to qualify as an expert center, deep experience is critical for safely managing bone sarcomas ^[2]. For local control (the procedure to permanently remove the primary tumor), teams must carefully plan the initial biopsy. Research shows that having the biopsy and the definitive tumor resection performed at different centers without tight coordination is an independent risk factor for a poorer prognosis and a higher rate of local tumor recurrence ^[4]. If your child already had a biopsy elsewhere, do not panic, but immediately request that the surgical team and pediatric pathologists review the biopsy tract and slides.

Additionally, ask about both limb salvage (surgery that removes the tumor while saving the limb using metal implants or bone grafts) and amputation. While limb salvage is a common goal, it is not always the safest choice for cancer control and carries a higher risk of complications and future reoperations ^[5].

Questions to ask:

• “How many pediatric osteosarcoma cases and complex bone reconstructions does your orthopedic oncology (bone tumor surgery) team perform annually?”
• “Who plans the biopsy, and will the biopsy tract be removed en bloc (in one piece) during the final surgery?”
• “What are the specific risks, functional outcomes, and expected complications for limb-salvage surgery versus amputation for my child’s specific tumor?”

2. Multidisciplinary Care and Pathology Review

Osteosarcoma care requires close coordination among pediatric oncologists, orthopedic surgeons, specialized radiologists, and pathologists ^[6]. A multidisciplinary tumor board is a formal meeting where these experts review a patient’s case together. Studies of pediatric solid tumors show that formal tumor board reviews frequently lead to important changes in image interpretation, pathology findings, and overall treatment plans ^[7]. Furthermore, in broad sarcoma registries, having a case reviewed by a multidisciplinary board combined with surgery at a reference center is correlated with improved disease control and overall survival ^[8].

Questions to ask:

• “Do you have a dedicated multidisciplinary sarcoma tumor board?”
• “When feasible, will my child’s imaging and pathology be reviewed by this board before we finalize the definitive treatment plan?”
• “If my child was diagnosed at another hospital, who on your team will review the outside pathology slides and MRI scans?”

3. Treatment Timing and Hospital Capabilities

In osteosarcoma treatment, timeliness and infrastructure are vital. Logistical delays in scheduling the local-control surgery or completing chemotherapy cycles by more than four weeks have been independently associated with worse survival outcomes in pediatric cohorts ^[3][9]. However, it is important to distinguish logistical delays (like bed shortages) from medical delays. Medically necessary delays—such as waiting for your child’s blood counts to recover or treating an infection—are critical for safety and should not be rushed.

Questions to ask:

• “What is your typical timeline from diagnosis to starting chemotherapy, and from chemotherapy to surgery?”
• “How do you handle hospital bed constraints or scheduling backups to avoid logistical delays in my child’s treatment?”
• “How do you monitor and manage severe treatment toxicities—such as those from high-dose methotrexate—so that my child’s treatment stays as close to schedule as safely possible?”

4. Comprehensive Support and Emergencies

A premier center must be able to support a child receiving intensive chemotherapy and major reconstruction. This includes managing acute emergencies (like fevers when the immune system is weak) and providing long-term survivorship care.

Questions to ask:

• “Who do we contact for emergencies or fevers after hours, and is there a dedicated pediatric oncology inpatient unit?”
• “What pediatric rehabilitation and physical therapy services are available to help my child recover mobility after surgery?”
• “What psychosocial, child-life, and fertility preservation services are available for our family before treatment begins?”

5. Access to Clinical Trials and Research

Clinical trials systematically evaluate new treatments or adjustments to current protocols. Access to clinical trials is an important part of pediatric oncology ^[10]. However, trial participation is always voluntary. A clinical trial may involve unknown risks, extra visits, or randomized treatments, and standard care remains highly effective.

Questions to ask:

• “What pediatric osteosarcoma clinical trials do you currently have open, and would my child be eligible?”
• “What are the known risks, alternatives, and additional requirements of this trial compared to standard treatment?”
• “If my child’s disease does not respond well to standard chemotherapy, do you have early-phase trial options available here or at partner centers?”